Project Affinity: Excess Cancer Blood Testing

Project Affinity: Excess Cancer Blood Testing Technique

Status

Completed

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT04724005

Enrollment

613

Registered

2021-01-26

Start date

2021-04-15

Completion date

2022-08-31

Last updated

2022-09-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cancer

Brief summary

Study investigating cancer blood samples on an iterative measurement systme

Interventions

OTHERNo drug

No drug used

Study design

Observational model

OTHER

Time perspective

RETROSPECTIVE

Eligibility

Sex/Gender

ALL

Age

18 Years to No maximum

Healthy volunteers

Inclusion criteria

* Undergoing SACT * Routine blood tests

Exclusion criteria

* Not had first cycle of SACT

Design outcomes

Primary

Measure	Time frame	Description
Viability of measurement technique	12 months	Viability of measurement technique

Countries

United Kingdom

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026